Director of Clinical Research, Division of Lymphoma / Associate Professor of Medicine Dana-Farber Cancer Institute / Harvard Medical School Boston, Massachusetts
Learning Objectives:
Incorporate guideline recommendations for cytogenetic analysis and minimal residual disease (MRD) monitoring into the care of patients with CLL/SLL